Bach Chen, CEO of Maisense, highlights the innovative new solutions that the company has created in cardiovascular preventative medicine. Their advanced technology, Freescan, is providing an advanced solution to prevent stroke through Artificial Intelligence. Chen goes on to share the Maisense strategy as a nontraditional startup shaping the way for Taiwan’s emerging medical device sector.
We do not have the strength to compete with traditional players, so being digitally disruptive is our key asset
